| For: | Wang D, Wang YS, Zhao HM, Lu P, Li M, Li W, Cui HT, Zhang ZY, Lv SQ. Plantamajoside improves type 2 diabetes mellitus pancreatic β-cell damage by inhibiting endoplasmic reticulum stress through Dnajc1 up-regulation. World J Diabetes 2025; 16(2): 99053 [PMID: 39959264 DOI: 10.4239/wjd.v16.i2.99053] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/99053.htm |
| Number | Citing Articles |
| 1 |
Kun Xiong, Wei-Tao Yan, Na Liu. Plantamajoside: A potentially novel botanical agent for diabetes mellitus management. World Journal of Diabetes 2025; 16(5): 104311 doi: 10.4239/wjd.v16.i5.104311
|
| 2 |
Nabil Eid, Payal Bhatnagar, Fabian Davamani, Md Abdul Alim Al-Bari. Plantamajoside mitigates endoplasmic reticulum stress-mediated pancreatic β-cell apoptosis in type 2 diabetes <i>via</i> DNAJC1 upregulation. World Journal of Diabetes 2025; 16(4): 104241 doi: 10.4239/wjd.v16.i4.104241
|
| 3 |
Pai Zhang, Yabin Cui, Chunyan Liu, Chengji Cui, Shoulin Zhang, Yue Zhang, Fan Li. Advances regarding the mechanism of endoplasmic reticulum stress in diabetic kidney disease and pharmacological interventions (Review). Molecular Medicine Reports 2025; 33(2): 1 doi: 10.3892/mmr.2025.13778
|
| 4 |
Hongmin Zhao, Renlin Li, Xuan Guo, Jingrui Kang, Huajun Li, Xiaoyun Wang, Yuansong Wang, Huantian Cui, Shuquan Lv, Weibo Wen, Zhongyong Zhang, Kai Huang. Mechanism of Plantamajoside in inhibiting ferroptosis of pancreatic β cells and treatment of T2DM via activation of the xCT/GPX4 pathway. PLOS One 2025; 20(6): e0325674 doi: 10.1371/journal.pone.0325674
|
